title: Management of COPD exacerbations.
abstract: Exacerbations of chronic obstructive pulmonary disease contribute to the high mortality rate associated with the disease. Randomized controlled trials have demonstrated the effectiveness of multiple interventions. The first step in outpatient management should be to increase the dosage of inhaled short-acting bronchodilators. Combining ipratropium and albuterol is beneficial in relieving dyspnea. Oral corticosteroids are likely beneficial, especially for patients with purulent sputum. The use of antibiotics reduces the risk of treatment failure and mortality in moderately or severely ill patients. Physicians should consider antibiotics for patients with purulent sputum and for patients who have inadequate symptom relief with bronchodilators and corticosteroids. The choice of antibiotic should be guided by local resistance patterns and the patient's recent history of antibiotic use. Hospitalized patients with exacerbations should receive regular doses of short-acting bronchodilators, continuous supplemental oxygen, antibiotics, and systemic corticosteroids. Noninvasive positive pressure ventilation or invasive mechanical ventilation is indicated in patients with worsening acidosis or hypoxemia.
authors.affiliation: University of Wisconsin School of Medicine and Public Health, 100 N. Nine Mound Rd., Verona, WI 53593, USA. ann.evensen@uwmf.wisc.edu
authors.forename: Ann E
authors.initials: AE
authors.lastname: Evensen
mesh_terms: D000420:Albuterol / Q000008:administration & dosage; D000900:Anti-Bacterial Agents / Q000008:administration & dosage; D001993:Bronchodilator Agents / Q000008:administration & dosage; D015897:Comorbidity; D018450:Disease Progression; D005938:Glucocorticoids / Q000008:administration & dosage; D006333:Heart Failure / Q000453:epidemiology; D006760:Hospitalization; D006801:Humans; D010100:Oxygen / Q000008:administration & dosage; D029424:Pulmonary Disease, Chronic Obstructive / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology / Q000628:therapy*; D012121:Respiration, Artificial; D013183:Sputum / Q000382:microbiology
chemical_list: D000900:Anti-Bacterial Agents; D001993:Bronchodilator Agents; D005938:Glucocorticoids; D000420:Albuterol; D010100:Oxygen